Business
Endonovo Therapeutics Inc. Featured in Exclusive NetworkNewsWire Broadcast
Endonovo Therapeutics Inc. Featured in Exclusive NetworkNewsWire Broadcast.
About this update from Endonovo Therapeutics, Inc.
[{"type":"text","content":"\nNEW YORK, July 22, 2019 (GLOBE NEWSWIRE) -- via NetworkNewsAudio – Endonovo Therapeutics Inc. (OTCQB: ENDV), an innovative biotechnology company and commercial-stage developer of noninvasive Electroceutical™ therapeutic devices, today announces the broadcast of its exclusive audio interview with NetworkNewsAudio (NNA), a NetworkNewsWire (NNW) solution that delivers clients unparalleled visibility, recognition and brand awareness in the investment community.\n The interview can be heard at http://nnw.fm/ZuFB3 Alan Collier, chairman and CEO of Endonovo Therapeutics, joins NNW host Stuart Smith for an in-depth discussion on the company’s flagship product, the SofPulse® Electroceutical™ Therapy device that many medical experts see as a potential solution to the nation’s opioid crisis. Described as an easy-to-place, non-invasive device that delivers targeted pulsed electromagnetic frequencies (tPEMF) to enhance post-surgical recovery, SofPulse has been cleared by the U.S. Federal Drug Administration (“FDA”) for the safe, palliative treatment of post-operative pain and to reduce edema (swelling). “The opioid crisis is here and affecting everyday Americans and surgical patients worldwide,” Collier says. “Anyone having a surgery, experiencing pain and being prescribed opioids is at risk of becoming addicted to opioids. The numbers are horrific.” “The average rate of later opioid dependency and addiction among patients with soft tissue and orthopedic operations is 12%, according to statistics released by the National Surveys on Drug Use and Health, the National Center for Health Statistics and the U.S. Department of Health and Human Services. More than 17,000 deaths were attributed to overdosing on commonly prescribed opioids,” Collier says. “There are 130 people dying every day from an opioid-related overdose and there are more than 11.4 million people that have misused opioids,” he adds, noting that “the most alarming statistic of all is that 80% of people addicted to heroin first misused prescription opioids.” Designed to deliver pulsed electromagnetic frequencies, Endonovo’s SofPulse® device can be used as a standalone therapy or as part of a treatment protocol. The pulsed electromagnetic therapy aids in the reducti...